Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation

Audrey Bettoun; Carine Joffre; Giulia Zago; Didier Surdez; David Vallerand; Ramazan Gundogdu; Ahmad A.D. Sharif; Marta Gomez; Ilaria Cascone; Brigitte Meunier; Michael A. White; Patrice Codogno; Maria Carla Parrini; Jacques H. Camonis; Alexander Hergovich

doi:10.18632/oncotarget.25335

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation

PDF | How to cite

Oncotarget. 2018; 9:22870-22870. https://doi.org/10.18632/oncotarget.25335

Metrics: PDF 1500 views | ?

Audrey Bettoun¹, Carine Joffre^1,5,*, Giulia Zago^1,*, Didier Surdez¹, David Vallerand¹, Ramazan Gundogdu², Ahmad A.D. Sharif², Marta Gomez², Ilaria Cascone¹, Brigitte Meunier¹, Michael A. White³, Patrice Codogno⁴, Maria Carla Parrini¹, Jacques H. Camonis¹ and Alexander Hergovich²

¹Institut Curie, Inserm U830, Paris Sciences et Lettres University Paris, 75248, France
²University College London, Cancer Institute, London, WC1E 6BT, United Kingdom
³University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA
⁴Inserm U1151-CNRS UMR 8253, Institut Necker Enfants-Malades, Paris, 75993, France
⁵Present address: Cancer Research Center of Toulouse, UMR1037, Toulouse, 31100, France
^*These authors have contributed equally to this work

Published: April 27, 2018

This article has been corrected: The correct Grant Support information is given below:

GRANT SUPPORT

This work was supported by the Wellcome Trust Research Career Development fellowship 090090/Z/09/Z (to A. Hergovich); the BBSRC grant BB/I021248/1 (to A. Hergovich); the National Institute for Health Research University College London Hospitals Biomedical Research Centre; the Ministry of National Education of the Republic of Turkey (to R. Gundogdu); the Ligue Nationale contre le cancer (LNCC) grants RD14/75-80 (to J. Camonis) and RS14/75-54 (to M.C. Parrini); the Fondation ARC grant SFI20121205710 (to M.C. Parrini); the ARC grant SFI20111203931 (to J. Camonis); the ANR grant ANR-13-CESA-0010-001 (to P. Codogno); the Association Christelle Bouillot; INCA; and institutional INSERM and CNRS funding. Work was supported also by grant ANR-08-NLAN-0290-01 to J. Camonis.

Original article: Oncotarget. 2016; 7:44142-44160. DOI: https://doi.org/10.18632/oncotarget.9875.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25335

Publication Alerts

Corrections:

Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation